ZD1839, a selective epidermal growth factor receptor...

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non–small cell lung cancer

David Raben, Barbara A. Helfrich, Dan Chan, Gary Johnson, Paul A. Bunn Jr
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Year:
2002
Language:
english
Pages:
10
DOI:
10.1053/sonc.2002.31521
File:
PDF, 107 KB
english, 2002
Conversion to is in progress
Conversion to is failed